News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
188,444 Results
Type
Article (9028)
Company Profile (59)
Press Release (179354)
Multimedia
Podcasts (21)
Webinars (6)
Section
Business (55322)
Career Advice (97)
Deals (9793)
Drug Delivery (10)
Drug Development (29385)
Employer Resources (12)
FDA (4443)
Job Trends (4095)
News (97923)
Policy (7446)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (405)
Accelerated approval (12)
Adcomms (13)
Allergies (18)
Alliances (17528)
ALS (31)
Alzheimer's disease (254)
Antibody-drug conjugate (ADC) (267)
Approvals (4656)
Artificial intelligence (182)
Autoimmune disease (56)
Automation (6)
Bankruptcy (62)
Best Places to Work (3618)
BIOSECURE Act (1)
Biosimilars (106)
Biotechnology (54)
Bladder cancer (139)
Brain cancer (48)
Breast cancer (481)
Cancer (3610)
Cardiovascular disease (45)
Career advice (90)
Career pathing (5)
CAR-T (128)
CDC (3)
Cell therapy (292)
Cervical cancer (22)
Clinical research (26239)
Collaboration (803)
Company closure (2)
Compensation (220)
Complete response letters (14)
COVID-19 (530)
CRISPR (25)
C-suite (318)
Cystic fibrosis (14)
Data (2595)
Decentralized trials (1)
Denatured (3)
Depression (22)
Diabetes (64)
Diagnostics (1907)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (110)
Drug pricing (25)
Drug shortages (1)
Duchenne muscular dystrophy (55)
Earnings (20306)
Editorial (12)
Employer branding (2)
Employer resources (13)
Events (30434)
Executive appointments (354)
FDA (5510)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (2)
Funding (421)
Gene editing (46)
Generative AI (16)
Gene therapy (113)
GLP-1 (180)
Government (673)
Grass and pollen (1)
Guidances (114)
Healthcare (4874)
HIV (8)
Huntington's disease (5)
IgA nephropathy (27)
Immunology and inflammation (73)
Immuno-oncology (56)
Indications (55)
Infectious disease (581)
Inflammatory bowel disease (52)
Inflation Reduction Act (3)
Influenza (26)
Intellectual property (81)
Interviews (12)
IPO (4271)
IRA (8)
Job creations (686)
Job search strategy (78)
JPM (27)
Kidney cancer (16)
Labor market (8)
Layoffs (143)
Leadership (6)
Legal (1360)
Liver cancer (57)
Longevity (1)
Lung cancer (537)
Lymphoma (228)
Machine learning (14)
Management (3)
Manufacturing (201)
MASH (16)
Medical device (1968)
Medtech (1978)
Mergers & acquisitions (5896)
Metabolic disorders (168)
Multiple sclerosis (30)
NASH (2)
Neurodegenerative disease (48)
Neuropsychiatric disorders (13)
Neuroscience (510)
NextGen: Class of 2026 (1126)
Non-profit (552)
Now hiring (17)
Obesity (81)
Opinion (38)
Ovarian cancer (136)
Pain (35)
Pancreatic cancer (167)
Parkinson's disease (62)
Partnered (4)
Patents (136)
Patient recruitment (185)
Peanut (3)
People (17359)
Pharmaceutical (12)
Pharmacy benefit managers (5)
Phase 1 (9264)
Phase 2 (11060)
Phase 3 (8721)
Pipeline (1984)
Policy (33)
Postmarket research (657)
Preclinical (3037)
Press Release (4)
Prostate cancer (176)
Psychedelics (4)
Radiopharmaceuticals (199)
Rare diseases (188)
Real estate (1279)
Recruiting (5)
Regulatory (6818)
Reports (13)
Research institute (755)
Resumes & cover letters (11)
RNA editing (4)
RSV (12)
Schizophrenia (51)
Series A (81)
Series B (50)
Service/supplier (2)
Sickle cell disease (41)
Special edition (3)
Spinal muscular atrophy (21)
Sponsored (7)
Startups (1105)
State (1)
Stomach cancer (12)
Supply chain (23)
Tariffs (8)
The Weekly (18)
Vaccines (219)
Venture capital (38)
Weight loss (30)
Women's health (9)
Date
Today (7)
Last 7 days (194)
Last 30 days (784)
Last 365 days (10194)
2026 (998)
2025 (10201)
2024 (11729)
2023 (13320)
2022 (18280)
2021 (18043)
2020 (15524)
2019 (11405)
2018 (8559)
2017 (9808)
2016 (8757)
2015 (10162)
2014 (7013)
2013 (5333)
2012 (5737)
2011 (5865)
2010 (5409)
Location
Africa (151)
Alabama (22)
Alaska (1)
Arizona (36)
Arkansas (2)
Asia (28146)
Australia (3608)
California (3467)
Canada (1014)
China (781)
Colorado (84)
Connecticut (138)
Delaware (237)
Europe (31001)
Florida (445)
Georgia (23)
Idaho (6)
Illinois (321)
India (41)
Indiana (110)
Iowa (9)
Japan (319)
Kansas (15)
Kentucky (13)
Louisiana (1)
Maine (8)
Maryland (399)
Massachusetts (2772)
Michigan (30)
Minnesota (141)
Missouri (14)
Montana (7)
Nebraska (3)
Nevada (18)
New Hampshire (10)
New Jersey (1071)
New Mexico (3)
New York (910)
North Carolina (279)
Northern California (1785)
Ohio (65)
Oklahoma (1)
Oregon (6)
Pennsylvania (538)
Puerto Rico (2)
Rhode Island (6)
South America (209)
South Carolina (3)
Southern California (1403)
Tennessee (37)
Texas (572)
United States (11978)
Utah (97)
Virginia (67)
Washington D.C. (11)
Washington State (335)
Wisconsin (40)
188,444 Results for "redx oncology ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program
Jazz Pharmaceuticals plc and Redx Pharma plc announced that the companies have signed a definitive agreement under which Jazz will acquire Redx’s KRAS inhibitor program.
February 7, 2024
·
6 min read
Press Releases
Faron Pharmaceuticals Ltd: Appointment of CFO
December 1, 2025
·
3 min read
Business
Jazz Inks Potential $880M Deal with Redx to Buy KRAS Inhibitors
Jazz Pharmaceuticals is acquiring Redx Pharma’s KRAS inhibitor program including preclinical-stage drug candidates, with the companies working to advance assets through IND-enabling studies.
February 7, 2024
·
2 min read
·
Tyler Patchen
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
Press Releases
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM
February 5, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Press Releases
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment
December 3, 2025
·
4 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
·
8 min read
1 of 18,845
Next
